Kenichi Harada - Search Results

Year	Number of Results
2002	17
2003	15
2004	18
2005	28
2006	23
2007	25
2008	17
2009	29
2010	21
2011	30
2012	26
2013	39
2014	36
2015	27
2016	30
2017	34
2018	33
2019	24
2020	37
2021	40
2022	38
2023	36
2024	17

1

RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.

Tanaka A, Tsuji K, Komiyama Y, Tsuruya K, Kakisaka K, Tsutsui A, Ichimoto K, Ueno M, Okazaki Y, Kamimura H, Takai A, Yamashiki N, Ito T, Watanabe M, Abe M, Harada KI, Kagawa T. Tanaka A, et al. Hepatol Res. 2024 Apr 20. doi: 10.1111/hepr.14046. Online ahead of print. Hepatol Res. 2024. PMID: 38642343

2

Kerr-Enhanced Optical Spring.

Otabe S, Usukura W, Suzuki K, Komori K, Michimura Y, Harada KI, Somiya K. Otabe S, et al. Phys Rev Lett. 2024 Apr 5;132(14):143602. doi: 10.1103/PhysRevLett.132.143602. Phys Rev Lett. 2024. PMID: 38640396

3

Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis.

Lyu J, Okada H, Sunagozaka H, Kawaguchi K, Shimakami T, Nio K, Murai K, Shirasaki T, Yoshida M, Arai K, Yamashita T, Tanaka T, Harada K, Takamura T, Kaneko S, Yamashita T, Honda M. Lyu J, et al. Among authors: harada k. Hepatol Commun. 2024 Apr 12;8(5):e0425. doi: 10.1097/HC9.0000000000000425. eCollection 2024 May 1. Hepatol Commun. 2024. PMID: 38619434 Free PMC article.

4

Clinicopathological features of cholangiolocarcinoma and impact of tumor heterogeneity on prognosis: A single institution retrospective study.

Sugita H, Nakanuma S, Gabata R, Tokoro T, Takei R, Okazaki M, Kato K, Takada S, Makino I, Kozaka K, Harada K, Yagi S. Sugita H, et al. Among authors: harada k. Oncol Lett. 2024 Mar 15;27(5):213. doi: 10.3892/ol.2024.14346. eCollection 2024 May. Oncol Lett. 2024. PMID: 38572060 Free PMC article.

5

Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study.

Furubayashi N, Minato A, Tomoda T, Hori Y, Kiyoshima K, Negishi T, Haraguchi Y, Koga T, Harada K, Kuroiwa K, Fujimoto N, Nakamura M; Uro-Oncology Group in Kyushu (UROKYU). Furubayashi N, et al. Among authors: harada k. Anticancer Res. 2024 Apr;44(4):1675-1681. doi: 10.21873/anticanres.16966. Anticancer Res. 2024. PMID: 38537962

6

Treatment Outcomes of Second-Line Systemic Therapy for Neuroendocrine Prostate Cancer: A Report of Four Cases.

Tsubonuma Y, Funakoshi K, Takaba T, Jyojima K, Minato A, Tomisaki I, Harada K, Fujimoto N. Tsubonuma Y, et al. Among authors: harada k. J UOEH. 2024;46(1):23-28. doi: 10.7888/juoeh.46.23. J UOEH. 2024. PMID: 38479871 Free article.

7

Reactive lymphoid hyperplasia of the liver: A case report featuring characteristic nodular and perinodular enhancement.

Osanai H, Kozaka K, Yoneda N, Yoshida K, Kitao A, Gabata T, Harada K, Makino I, Kobayashi S. Osanai H, et al. Among authors: harada k. Radiol Case Rep. 2024 Feb 29;19(5):1998-2003. doi: 10.1016/j.radcr.2024.02.029. eCollection 2024 May. Radiol Case Rep. 2024. PMID: 38440741 Free PMC article.

8

Mobilize a Proton to Transform the Collision-Induced Dissociation Spectral Pattern of a Cyclic Peptide.

Nakamura T, Hongo Y, Harada KI. Nakamura T, et al. Mass Spectrom (Tokyo). 2024;13(1):A0144. doi: 10.5702/massspectrometry.A0144. Epub 2024 Feb 23. Mass Spectrom (Tokyo). 2024. PMID: 38435076 Free PMC article.

9

Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan.

Hara T, Matsushita Y, Harada K, Fujimoto N, Fujisawa M, Miyake H. Hara T, et al. Among authors: harada k. Int J Urol. 2024 Feb 29. doi: 10.1111/iju.15435. Online ahead of print. Int J Urol. 2024. PMID: 38424707 No abstract available.

10

Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology.

Minato A, Murooka K, Okumura Y, Takaba T, Higashijima K, Nagata Y, Tomisaki I, Harada K, Fujimoto N. Minato A, et al. Among authors: harada k. In Vivo. 2024 Mar-Apr;38(2):873-880. doi: 10.21873/invivo.13513. In Vivo. 2024. PMID: 38418119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

565 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

565 results

Results by year